Search

everythinglearnresearchcommunity

for

Search:↓

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.

Hair loss is a common side effect of hormone treatments for cancer.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

The document concludes that recent studies help tell apart desmoplastic trichoepitheliomas from other skin tumors, but more research is needed for clear differentiation.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Early treatment is important for better hair regrowth in elderly women with hair loss.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.